Keywords: baxter, cerus, hold, red, blood, cell, ph

Baxter and Cerus hold red blood cell Ph III trial

Article | 15 September 2003

Print This

US firms Cerus Corp and subsidiaries of Baxter International say they are voluntarily halting Phase III trials for their pathogen-inactivated ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in